Regional footprint Tridem Pharma has an established distribution and regulatory affairs presence across nearly 90% of Africa and a focus on Middle East markets, offering a ready-made path for new product launches and market access through its mature sales network.

Strategic ownership As a subsidiary of Fosun Pharma since 2017, Tridem benefits backing from a large international group, which can facilitate co-promotion, licensing, and capital for expanding portfolio uptake in targeted regions.

Comprehensive services The company provides end-to-end capabilities including medical promotion, distribution, regulatory affairs and pharmacovigilance, enabling a turnkey entry for manufacturers seeking rapid market penetration in stability- and quality-conscious markets.

Industry alignment With expertise in pharmaceuticals, dermo-cosmetics and IVD/rapid tests, Tridem aligns with growing demand for diagnostics and consumer health products in Africa and the Middle East, presenting cross-sell opportunities for related product categories.

Growth potential Revenue range suggests a mid-size platform with room for expansion; targeting collaborations with mid- to large-cap pharma partners looking to scale in Francophone and Anglophone Africa could unlock incremental volumes and new geographic wins.